SII to acquire 20% stake in IntegriMedical : vimarsana.com

IntegriMedical has developed a US patented needle-free Injection System (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs, Serum Institute of India (SII) said in a statement.

Related Keywords

United States , India , Australia , Adar Poonawalla , Sarvesh Mutha , Serum Institute Of India , Device Single Audit Program , Central Drugs Standard Control Organisation , Serum Institute , Injection System , Medical Device Single Audit Program , Injections System , Medical Managing Director Sarvesh Mutha ,